The Patent Finder
US

Anti-Cancer Nuclear Hormone Receptor-Targeting Compounds

US 12,398,121 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 14, 2039 · High confidence

Filed Nov 22, 2022 as application 18/058,220 · Granted Aug 26, 2025
Base term, 20 years from filing
Today
20 years from filing
2019 2039
Clock starts
May 14, 2019
Term ends
May 14, 2039
Granted
Aug 26, 2025
base term Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 14, 2019, when application 16/412,319, the earliest non-provisional in its chain, was filed (this one was filed Nov 22, 2022)May 14, 2039High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 14, 2039High confidence

This family

Application 16/412,319Abandoned
not computed
not computed
US 12,398,121this patent
May 2039
May 2039
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 12, 2022
Reel 62060, frame 311
Barde, Anup; Nayak, Anjan KumarIntegral Biosciences PVT. Ltd.Assignment of Assignor's Interest
Dec 12, 2022
Reel 62060, frame 445
Integral Biosciences PVT. Ltd.Sparcbio LLCAssignment of Assignor's Interest
Dec 12, 2022
Reel 62115, frame 924
Pham, Son Minh; Chakravarty, Sarvajit; Chen, Jiyun; Jayakanth KankanalaSparcbio LLCAssignment of Assignor's Interest
Dec 12, 2022
Reel 62060, frame 529
Sparcbio LLCNuvation Bio Inc.Assignment of Assignor's Interest
Dec 12, 2022
Reel 62115, frame 960
Hung, DavidNuvation Bio Inc.Assignment of Assignor's Interest
Mar 4, 2025
Reel 70400, frame 200
Nuvation Bio Inc.Sagard Holdings Manager LP, as Administrative AgentSecurity Interest
Jul 6, 2026
Reel 75179, frame 564
Sagard Holdings Manager LP, as Administrative AgentNuvation Bio Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited